Evidence map›Paper›PMID 40076532›Full record

ArticleInternational journal of molecular sciences2025

Evaluation of Metal Accumulation in

Yasunori Fukumoto, Enhui Li, Yu-Ki Tanaka, Noriyuki Suzuki, Yasumitsu Ogra

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasunori FukumotoGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.ORCID 0009-0008-3126-8970
Enhui LiGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
Yu-Ki TanakaGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.ORCID 0000-0001-8298-7408
Noriyuki SuzukiGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.
Yasumitsu OgraGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.ORCID 0000-0002-8268-1828

Funding

Agilent Technologies (Japan) 4366Agilent Technologies (Japan) 4489Ministry of Education, Culture, Sports, Science and Technology 22K05345Ministry of Education, Culture, Sports, Science and Technology 24H00749Ministry of Education, Culture, Sports, Science and Technology 24K09793Ministry of Education, Culture, Sports, Science and Technology 24K21304
6 · The paper itself

Abstract

Rare earth elements, comprising 17 elements including 15 lanthanides, are essential components in numerous high-tech applications. While physicochemical methods are commonly employed to remove toxic heavy metals (e.g., cadmium and mercury) from industrial wastewater, biological approaches offer increasingly attractive alternatives. Biomining, which utilizes microorganisms to extract valuable metals from ores and industrial wastes, and bioremediation, which leverages microorganisms to adsorb and transport metal ions into cells via active transport, provide eco-friendly solutions for resource recovery and environmental remediation. In this study, we investigated the potential of three recently identified lanthanide-binding proteins-SPL2, lanpepsy, and lanmodulin-for applications in these areas using single-cell inductively coupled plasma mass spectrometry (scICP-MS). Our results demonstrate that SPL2 exhibits superior characteristics for lanthanide and cadmium bioremediation. Heterologous expression of a cytosolic fragment of SPL2 in bacteria resulted in high expression levels and solubility. Single-cell ICP-MS analysis revealed that these recombinant bacteria accumulated lanthanum, cobalt, nickel, and cadmium, effectively sequestering lanthanum and cadmium from the culture media. Furthermore, SPL2 expression conferred enhanced bacterial tolerance to cadmium exposure. These findings establish SPL2 as a promising candidate for developing recombinant bacterial systems for heavy metal bioremediation and rare earth element biomining.

Indexed as

Escherichia coliMetals, HeavyBiodegradation, EnvironmentalCadmiumLanthanoid Series ElementsMass SpectrometrySingle-Cell AnalysisCadmiumLanthanoid Series ElementsMetals, HeavybiominingbioremediationcadmiumscICP-MSsingle-cell inductively coupled plasma mass spectrometrySPL2

Identifiers

PMID40076532
PMCPMC11899968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.